J+
JOHNSON + JOHNSON
JNJ· Health Care· PharmaceuticalsS&P 500
Close · 12/10/2026
263.73
1D
+0.88%52-week range
184.66 – 281.07
Volume
59,02,500.00
Price history
JNJ
11/09/2026 to 12/10/2026
O 261.60 H 264.39 L 260.37
1W+4.27%
1M-0.70%
3M+3.89%
6M+10.83%
1Y+38.02%
3Y+67.83%
5Y+65.64%
MAX+51.82%
Fundamentals
as of 12/10/2026- Market cap
- $635.56B
- Shares out
- 2.41B
- P/E (trailing)
- 30.21
- P/E (forward)
- 21.60
- EPS (trailing)
- 8.73
- Dividend yield
- 2.00%
- Beta
- 0.21
- Profit margin
- 21.48%
- P/B
- 7.48
- Return on equity
- 24.76%
SEC financial statements
68 quarterly and 19 annual periods through 28/06/2026.
Details
- Ticker
- JNJ
- Index
- SP500
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 12/10/2026.
Tracked by Congress
51 filers · 4 on watchlist · 94 buys · 70 sells · ?: 27 · R: 68 · D: 69
- 08/09/2026Lloyd DoggettBuyJohnson & Johnson Common Stock$1,001–$15,000
- 27/08/2026Thomas H. KeanSell+Johnson & Johnson Common Stock$1,001–$15,000
- 20/08/2026John BoozmanWSell+Johnson & Johnson Common Stock$1,001–$15,000
- 30/07/2026Richard Dean Dr McCormickSellJohnson & Johnson Common Stock$1,001–$15,000
- 29/10/2024Thomas H TubervilleWSellJohnson & Johnson Common Stock$15,001–$50,000
- 29/10/2024Thomas H TubervilleWSellJohnson & Johnson Common Stock$15,001–$50,000
- 30/03/2026Alan ArmstrongBuyJohnson & Johnson Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyJohnson & Johnson Common Stock$15,001–$50,000